DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Altretamine
Altretamine
Emetogenic Potential of Antineoplastic Agents
Original New Drug Applications
SUPPLEMENTARY FILE Cellular Fitnessphenotype of Cancer Target
How Chemotherapy Drugs Work
Chemotherapy Medications
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
Clinical Policy: Nabilone (Cesamet), Dronabinol (Marinol, Syndros)
CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS
Guidance on the Use of Paclitaxel in the Treatment of Ovarian Cancer
The Cost Burden of Blood Cancer Care a Longitudinal Analysis of Commercially Insured Patients Diagnosed with Blood Cancer
In Vitro Elucidation of the Metabolic Fate of the Anticancer Drug Busulfan
Hexalen (Altretamine) Capsules Prescribing Information
Cancer Drug Costs for a Month of Treatment at Initial Food
An Overview of Cancer (PDF)
Joint Meeting
NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010
Use of Anti-Emetics in Adults Receiving Anti-Cancer Drug Therapy
BCBSNM/HMONM Therapeutic Class Drug List (Formulary) 2004
Top View
NTP Monograph on the Systematic Review of Occupational Exposure to Cancer Chemotherapy Agents and Adverse Health Outcomes
Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
In Vitro Chemosensitivity Using the Histoculture Drug Response Assay in Human Epithelial Ovarian Cancer
Methotrexate 25Mg/Ml Solution for Injection - Summary of Product Characteristics (SPC) - (Emc)
Altretamine (Hexalen®) (“Al TRET a Meen”)
Carboplatin, Doxorubicin and Etoposide in the Treatment of Tumours of Unknown Primary Site
Medications That Are Immunosuppressive Or Immunomodulatory (This List Is Not All-Inclusive)
Emetogenic Potential of Antineoplastic Agents
The Cost Burden of Blood Cancer Care in Medicare a Longitudinal Analysis of Medicare Advantage and Fee for Service Patients Diagnosed with Blood Cancer
Chemotherapy-Induced Peripheral Neuropathy: a Literature Review Neuropatia Periférica Induzida Por Quimioterapia: Uma Revisão De Literatura
From Old Alkylating Agents to New Minor Groove Binders
Pharmacist Involvement in the Management of Adverse Effects
Hemodialysis Drug Removal
Supplementary Table 1. Summary of FDA-Approved Anticancer Cytotoxic Drugs at May 2019
Guide for Handling Cytotoxic Drugs and Related Waste
Oncology Agents Not Listed in Seer Book 8
List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
Emetogenic Potential of Antineoplastic Agents
Topotecan for Ovarian Cancer C Forbes L Shirran A-M Bagnall S Duffy G Ter Riet
HHS Public Access Author Manuscript
Peripheral Neuropathy in Ovarian Cancer
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
Year of FDA Monthly Cost Approval
NIOSH Alert: Preventing Occupational Exposures to Antineoplastic
An Open Access Database of Licensed Cancer Drugs Pan Pantziarka 1,2, §, Rica Capistrano 1, Arno De Potter 3, Liese Vandeborne 1, Gauthier Bouche 1
Recurrent Ovarian Cancer: How Important Is It to Treat to Disease Progression?
Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
The National Unui Al Contra Unitate
Hazardous Drug List
Medications That Are Considered Hazardous
Miscellaneous CT Drugs 2
Altretamine (Hexalen®) | UPMC Hillman Cancer Center
Antineoplastic Drugs